Compound RYR1 heterozygosity resulting in a complex phenotype of malignant hyperthermia susceptibility and a core myopathy.

MLA

Kraeva, N., et al. “Compound RYR1 Heterozygosity Resulting in a Complex Phenotype of Malignant Hyperthermia Susceptibility and a Core Myopathy.” Neuromuscular Disorders, 2015. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1284128787&authtype=sso&custid=ns315887.

APA

Kraeva, N., Heytens, L., Jungbluth, H., Treves, S., Voermans, N. C., Kamsteeg, E. J., Groote, C. C., Baets, J., & Riazi, S. (2015). Compound RYR1 heterozygosity resulting in a complex phenotype of malignant hyperthermia susceptibility and a core myopathy. Neuromuscular Disorders.

Chicago

Kraeva, N., L. Heytens, H. Jungbluth, S. Treves, N.C. Voermans, E.J. Kamsteeg, C. Ceuterick-de Groote, J. Baets, and S. Riazi. 2015. “Compound RYR1 Heterozygosity Resulting in a Complex Phenotype of Malignant Hyperthermia Susceptibility and a Core Myopathy.” Neuromuscular Disorders. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1284128787&authtype=sso&custid=ns315887.